Cancer Research Career Enhancement & Related Activities ABSTRACT The SKCC has a longstanding history in cancer education and training since inception in 1991. The Associate Director for Education, Jeffrey Benovic, PhD, and doctoral program leaders drive SKCC education activities with the support of SKCC-funded education coordinators under Dr. Benovic?s direction and oversight by the SKCC Training Committee. The overall goal of SKCC efforts is to create an integrated and innovative cancer research career enhancement program, which focuses on creating a pipeline of activities to develop the next generation of cancer researchers, and to provide career training and mentorship to those that are beginning their careers in cancer research. Specific programmatic activities are formulated around groups including underrepresented minority high school and undergraduate students, pre-doctoral and postdoctoral trainees, researchers, and clinicians. Development of these individuals enhances the depth, breadth, and impact of SKCC programs and fosters a well-defined, cohesive pipeline for cancer center member development. Current cancer-relevant activities include pre-doctoral and postdoctoral training, cross-training in cancer research, clinical research conferences, cancer focused seminar series, diversity training, career development activities, and extensive education and training activities within all SKCC Programs and Shared Resources. SKCC early career investigators also benefit from significant institutional support for cancer education and training activities and a large number of grants that support over 50 SKCC trainees. Development of a robust cancer research career development training pipeline, mentored development of junior faculty, and ongoing education and training of cancer researchers across the research spectrum is a fundamental goal of SKCC and consortium partners. We have identified and begun to implement several new initiatives to address underdeveloped areas and build strength in areas based on a review of progress against goals. These mechanisms include: 1) Cancer Research Data Club; 2) Trainee-only seminar series; 3) Quarterly workshop for trainees; 4) Annual Education Retreat; and 5) Funding opportunities for travel to cancer-focused meetings.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA056036-19S1
Application #
9759286
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Ptak, Krzysztof
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
19
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Peng, Weidan; Furuuchi, Narumi; Aslanukova, Ludmila et al. (2018) Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol 38:
Waldman, Scott A; Camilleri, Michael (2018) Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut 67:1543-1552
Sullivan-Reed, Katherine; Bolton-Gillespie, Elisabeth; Dasgupta, Yashodhara et al. (2018) Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells. Cell Rep 23:3127-3136
Lu, Huimin; Bowler, Nicholas; Harshyne, Larry A et al. (2018) Exosomal ?v?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol 70:20-35
Lapadula, Dominic; Farias, Eduardo; Randolph, Clinita E et al. (2018) Effects of Oncogenic G?q and G?11 Inhibition by FR900359 in Uveal Melanoma. Mol Cancer Res :
Vite, Alexia; Zhang, Caimei; Yi, Roslyn et al. (2018) ?-Catenin-dependent cytoskeletal tension controls Yap activity in the heart. Development 145:
McNair, Christopher; Xu, Kexin; Mandigo, Amy C et al. (2018) Differential impact of RB status on E2F1 reprogramming in human cancer. J Clin Invest 128:341-358
Garcia, Samantha A; Lebrun, Aurore; Kean, Rhonda B et al. (2018) Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant. J Neurovirol 24:606-615
Vido, Michael J; Le, Kaitlyn; Hartsough, Edward J et al. (2018) BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association. Cell Rep 25:1501-1510.e3
Brody, Jonathan R; Dixon, Dan A (2018) Complex HuR function in pancreatic cancer cells. Wiley Interdiscip Rev RNA 9:e1469

Showing the most recent 10 out of 807 publications